148 related articles for article (PubMed ID: 33600889)
1. Brain-Specific Relative Biological Effectiveness of Protons Based on Long-term Outcome of Patients With Nasopharyngeal Carcinoma.
Zhang YY; Huo WL; Goldberg SI; Slater JM; Adams JA; Deng XW; Sun Y; Ma J; Fullerton BC; Paganetti H; Loeffler JS; Lu HM; Chan AW
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):984-992. PubMed ID: 33600889
[TBL] [Abstract][Full Text] [Related]
2. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
[TBL] [Abstract][Full Text] [Related]
3. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
Gillmann C; Jäkel O; Schlampp I; Karger CP
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
[TBL] [Abstract][Full Text] [Related]
4. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
5. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
[TBL] [Abstract][Full Text] [Related]
6. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
7. A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy.
Eulitz J; Lutz B; Wohlfahrt P; Dutz A; Enghardt W; Karpowitz C; Krause M; Troost EGC; Lühr A
Phys Med Biol; 2019 Nov; 64(22):225020. PubMed ID: 31374558
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans.
Liu C; Zheng D; Bradley JA; Mailhot Vega RB; Zhang Y; Indelicato DJ; Mendenhall N; Liang X
Acta Oncol; 2021 Feb; 60(2):252-259. PubMed ID: 33063569
[TBL] [Abstract][Full Text] [Related]
9. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated intensity-modulated proton therapy for pharyngeal cancer with variable relative biological effectiveness: A simulation study.
Kasamatsu K; Matsuura T; Yasuda K; Miyazaki K; Takao S; Tamura M; Otsuka M; Uchinami Y; Aoyama H
Med Phys; 2022 Dec; 49(12):7815-7825. PubMed ID: 36300598
[TBL] [Abstract][Full Text] [Related]
11. Quantification of biological range uncertainties in patients treated at the Krakow proton therapy centre.
Garbacz M; Gajewski J; Durante M; Kisielewicz K; Krah N; Kopeć R; Olko P; Patera V; Rinaldi I; Rydygier M; Schiavi A; Scifoni E; Skóra T; Skrzypek A; Tommasino F; Rucinski A
Radiat Oncol; 2022 Mar; 17(1):50. PubMed ID: 35264184
[TBL] [Abstract][Full Text] [Related]
12. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
13. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
[TBL] [Abstract][Full Text] [Related]
14. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer.
Engeseth GM; Hysing LB; Yepes P; Pettersen HES; Mohan R; Fuller CD; Stokkevåg CH; Wu R; Zhang X; Frank SJ; Gunn GB
Acta Oncol; 2022 Feb; 61(2):215-222. PubMed ID: 34534047
[TBL] [Abstract][Full Text] [Related]
15. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
17. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
Giantsoudi D; Adams J; MacDonald S; Paganetti H
Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
[TBL] [Abstract][Full Text] [Related]
18. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
[TBL] [Abstract][Full Text] [Related]
19. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
20. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
